Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $159 million and $500 million for the fourth quarter and full year 2023, respectively... Read more.
Unlocking the Field: SciAps Inc. Introduces Revolutionary PowerHouse X – The Ultimate Portable Benchtop XRF for Geochemists
The portable X-Ray Fluorescence (XRF) comes with a 80kV (kilovolt) X-ray tube WOBURN, Mass.–(BUSINESS WIRE)–SciAps, a global leader in scientific instruments... Read more.
PAR Technology Corporation Announces Strategic Acquisitions to Expand Global Vision, Extend Unified Commerce Offerings and Accelerate Drive Towards Profitability
TASK Group Holdings Limited (ASX: TASK) and Stuzo Holdings, LLC, Enhance PAR’s Leadership in Unified Commerce for Foodservice & Retail Brands on a Global Scale... Read more.
Chirantan “CJ” Desai Appointed to MSCI Inc. Board of Directors
NEW YORK–(BUSINESS WIRE)–MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment community,... Read more.
Pentair to Present at J.P. Morgan Investor Conference
LONDON–(BUSINESS WIRE)–Pentair plc (NYSE:PNR), a leader in helping the world sustainably move, improve, and enjoy water, life’s most essential resource,... Read more.
NuScale Power to Participate in March and April 2024 Investor Conferences
PORTLAND, Ore.–(BUSINESS WIRE)–NuScale Power Corporation (NYSE: SMR), the industry-leading provider of proprietary and innovative advanced small modular... Read more.
Kylie Jenner is the Face of Sam Edelman’s Spring/Summer 2024 Campaign, to Kick-Off the Brand’s 20th Anniversary Celebration
NEW YORK–(BUSINESS WIRE)–Sam Edelman, the contemporary lifestyle brand celebrated for its iconic footwear and a lead brand in the Caleres (NYSE: CAL)... Read more.
Oxford Nanopore Technologies and SeqOne Partner to Support Interpretation of Nanopore Sequencing in Clinical Use
A new partnership will provide end-to-end solutions from sample to report for whole genome nanopore sequencing reads at scale in future clinical applications, including... Read more.
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update
– Sebetralstat Phase 3 KONFIDENT clinical trial met all endpoints and demonstrated a favorable safety profile as first oral on-demand therapy for hereditary... Read more.
OnMed Announces Karthik Ganesh as CEO
TAMPA, Fla.–(BUSINESS WIRE)–OnMed is pleased to announce the appointment of Karthik Ganesh to the role of CEO. OnMed’s patented CareStation, with its... Read more.